Skip to search formSkip to main contentSkip to account menu

CEA-Vac

Known as: CeaVac 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

Monoclonal Antibodiesmonoclonal antibody 3H1 anti-idiotype vaccine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
A Phase II Prospective Multi-Institutional Trial of Adjuvant Active Specific Immunotherapy Following Curative Resection of Colorectal Cancer Hepatic Metastases: Cancer and Leukemia Group B Study…
Background Patients with curatively resected colorectal cancer hepatic metastases often harbor occult metastatic disease and are… 
2007
2007
A Phase II Prospective Multi-institutional Trial of Adjuvant Active Specific Immunotherapy Following Curative Resection of Colorectal Cancer Hepatic Metastases: Cancer and Leukemia Group B Study…
BackgroundPatients with curatively resected colorectal cancer hepatic metastases often harbor occult metastatic disease and are… 
Review
2006
Review
2006
Monoclonal and bispecific antibodies as novel therapeutics
Abstract.Gene amplification, over-expression, and mutation of growth factors, or the receptors themselves, causes increased… 
2006
2006
Anti-Idiotype Antibody Vaccines for the Immunotherapy of Cancer
Certain anti-idiotypic (Id) antibodies that bind to the antigen-combining sites of antibodies can effectively mimic the three… 
2003
2003
`CeaVac' [Titan Pharmaceuticals] improves survival in metastatic colorectal cancer
  • 2003
  • Corpus ID: 195154099
Review
2002
Review
2002
Current concepts in immunotherapy for the treatment of colorectal cancer.
Immunotherapy could have a role in the therapy of colorectal cancer as there is now convincing evidence that the immune system… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)